Skip to content

News

Creating the perfect cup of coffee U of T researchers team up with Toronto roaster to refine process

Coffee roasting is an art, but University of Toronto researchers and a Toronto coffee company want to make it a science. U of T’s Impact Centre, an innovation hub that works with entrepreneurs and established companies, is teaming up with coffee company Cut Coffee to figure out how to manipulate the roasting process to bring … Read More

U of T startup inks $250,000 deal with local health network

A University of Toronto startup seeking to improve communication between patients and hospitals has received $250,000 in funding from a southern Ontario local health integration network. The Waterloo-Wellington LHIN said Friday the funding would be used by Dash MD to develop a local version of its smartphone app, which enables health-care providers to easily deliver detailed  … Read More

Canadian Tech Companies are Active on Social Media but Lack Conversion Rates

It seems that Canadian tech companies are putting in the effort when it comes to social media, but the returns might not be up to par. A new report from The Impact Centre at the University of Toronto shows that Canadian tech companies are creating and posting content on social media more than several other … Read More

Healthcare Innovation in Canada Hitting its Stride

The count is now in for this year’s Health Innovation Week at MaRS Discovery District. This year’s agenda grew from 24 to 37 events, ranging from investment in AI and health summits to early stage networking opportunities and medical research. The number of attendees was also impressive, jumping from 2,000 to more than 3,500, including … Read More

Deep Genomics Partners with U.S. Startup to Further Develop AI Platform

One of Canada’s leading genome startups is working with a notable U.S. partner to expand their knowledge in the space. Toronto’s Deep Genomics is collaborating with Cambridge’s Wave Life Sciences to help identify therapies for the treatment of genetic neuromuscular disorders. Deep Genomics will use their industry-leading machine-learning-driven biomedical platform to help Wave deliver their … Read More

Canada’s Technology VC Deals Had a Record-Setting Q1 in 2018

Often times, people speak in hyperbole when it comes to explaining just how quickly Canada’s tech and startup scene is growing. Sure, there’s reports, studies, and even blurbs from top tech personalities featuring words like explosive and unparalleled, but these explainers pale in comparison to hard numbers. So how about this: Canada’s 2018 Q1 saw the biggest … Read More

U of T conference explores the future of health care – and how Toronto will shape it

Having twice battled breast cancer, Nathalie Le Prohon has first-hand knowledge of the “dire need for change and transformation” of the aging and often inefficient Canadian health-care system. “We’re moving and innovation is happening, but it’s not scaling up fast enough,” Le Prohon, the health-care industry lead for IBM Canada, told a packed auditorium at … Read More

U of T’s Deep Genomics inks partnership with U.S. biotech firm

A University of Toronto startup that uses artificial intelligence to develop treatments for genetic diseases has forged a partnership with a U.S. biotechnology firm. Deep Genomics, spun out of research done by Professor Brendan Frey in the Faculty of Applied Science & Engineering, said this week it will be working with Cambridge, Mass.-based, Wave Life Sciences to … Read More

U of T’s Deep Genomics inks partnership with U.S. biotech firm

A University of Toronto startup that uses artificial intelligence to develop treatments for genetic diseases has forged a partnership with a U.S. biotechnology firm. Deep Genomics, spun out of research done by Professor Brendan Frey in the Faculty of Applied Science & Engineering, said this week it will be working with Cambridge, Mass.-based, Wave Life Sciences to … Read More

Nymi discusses meeting FDA eSignature requirements with biometrics

Authentication wearable provider Nymi has published a three-part blog on the value of electronic signatures based on biometrics to pharmaceutical manufacturers, not only for compliance with FDA regulations but also for improved data integrity and user productivity. The blog series, titled “Why FDA Title 21 CFR Part 11 matters more than ever,” starts with a … Read More